Evidence map›Paper›PMID 29146594›Full record

ArticleThe Journal of biological chemistry2018

Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.

András D Tóth, Susanne Prokop, Pál Gyombolai, Péter Várnai, András Balla, Vsevolod V Gurevich, László Hunyady, Gábor Turu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Aldosterone breakthrough from a pharmacological perspective.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. βAnnual review of pharmacology and toxicology · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors.Trends in pharmacological sciences · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

András D TóthFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.
Susanne ProkopFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0003-0790-9324
Pál GyombolaiFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0001-7117-6351
Péter VárnaiFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.
András BallaFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0002-6450-2793
Vsevolod V Gurevichthe Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232.ORCID 0000-0002-3950-5351
László HunyadyFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary, hunyady.laszlo@med.semmelweis-univ.hu.ORCID 0000-0002-8438-7251
Gábor TuruFrom the Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest H-1094, Hungary.ORCID 0000-0002-4421-3812
Semmelweis University · HUVanderbilt University · US

Funding

Targeted Engineering of Designer Arrestins to Regulate Cell SignalingR35GM122491 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2017 to 2021
$2.6M
Regulation of GPCR signaling with receptor-specific arrestinsR01GM109955 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2015 to 2017
$1.1M
NIGMS NIH HHS R01 GM109955NIGMS NIH HHS R35 GM122491
6 · The paper itself

Abstract

β-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and β-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether β-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of β-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, G

Indexed as

Angiotensin IIAnimalsbeta-ArrestinsChlorocebus aethiopsCOS CellsHEK293 CellsHumansImmunoblottingMicroscopy, ConfocalMitogen-Activated Protein KinasesPhosphorylationReceptors, G-Protein-CoupledAngiotensin IIbeta-ArrestinsMitogen-Activated Protein KinasesReceptors, G-Protein-Coupledangiotensin IIarrestinbioluminescence resonance energy transfer (BRET)G protein-coupled receptor (GPCR)mitogen-activated protein kinase (MAPK)protein kinase C (PKC)receptor endocytosis

Identifiers

PMID29146594
PMCPMC5777260
OpenAlexW2769386556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.